Literature DB >> 6148162

Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man.

M R Lucey, P D Fairclough, J A Wass, P Kwasowski, S Medbak, J Webb, L H Rees.   

Abstract

We have studied the effect of direct infusion of nutrients into the duodenum of normal subjects on circulating plasma somatostatin, insulin, gastrin and gastric inhibitory polypeptide (GIP) levels. Six normal subjects were given on four separate occasions 150 ml of isotonic solutions containing 100 calories of carbohydrate, protein, or fat, and a control solution of saline, by infusion into the second part of the duodenum. Plasma somatostatin rose slightly after carbohydrate, mean basal 30 +/- 3 pg/ml, peak 46 +/- 16 pg/ml at 15 min; and more markedly after protein, peak 57 +/- 9 pg/ml at 30 min. However, fat was the most potent intraduodenal stimulus to plasma somatostatin release into circulation, peak 101 +/- 11 pg/ml at 30 min. The plasma insulin rise was greatest after carbohydrate, peak 68 +/- 10 i.u., but there was a significant rise after protein also, peak 34 +/- 6 i.u. Plasma gastrin rose significantly after protein only, peak 70 +/- 22 pg/ml. Plasma GIP rose markedly after carbohydrate, basal 506 +/- 50 pg/ml, peak 1480 +/- 120 pg/ml. Protein was also a potent stimulus of circulating plasma GIP release, peak 1200 +/- 190 pg/ml, while fat was the least potent, peak 730 +/- 190 pg/ml. Thus, calorie for calorie, fat is the most potent intraduodenal nutrient stimulus of circulating somatostatin. We postulate therefore that somatostatin may be an enterogastrone--a circulating hormone released by intraduodenal fat which inhibits gastric acid secretion. Fat is the least potent intraduodenal nutrient stimulus of circulating GIP release. This is evidence against the hypothesis that circulating GIP acts as an enterogastrone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148162     DOI: 10.1111/j.1365-2265.1984.tb03461.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

Review 1.  Endogenous somatostatin and the gut.

Authors:  M R Lucey
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

2.  A physiologic role for somatostatin 28 as a regulator of insulin secretion.

Authors:  D A D'Alessio; C Sieber; C Beglinger; J W Ensinck
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

3.  Autonomic regulation of postprandial plasma somatostatin, gastrin, and insulin.

Authors:  M R Lucey; J A Wass; P Fairclough; J Webb; S Webb; S Medbak; L H Rees
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

4.  Effects of oleic acid and endogenous bile on duodenal secretion of somatostatin in man.

Authors:  O Olsen; J J Holst; O B Schaffalitzky De Muckadell
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

5.  Effect of secretin and somatostatin on secretion of epidermal growth factor from Brunner's glands in the rat.

Authors:  P S Olsen; P Kirkegaard; S S Poulsen; E Nexø
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.